Showing results (771-780 of 5,501) with videos related to
Sort By:
Pageof 551
Inflammatory Bowel Diseases|June 16, 2011
Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel diseaseWendy N Gray, Lee A Denson, Robert N Baldassano, et al.Inflammatory Bowel Diseases|June 16, 2011
Ability of commonly used prediction equations to predict resting energy expenditure in children with inflammatory bowel diseaseRebecca J Hill, Peter J Lewindon, Geoffrey D Withers, et al.Inflammatory Bowel Diseases|February 21, 2012
AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammationMaryline Drouet, Cécile Vignal, Elisabeth Singer, et al.Inflammatory Bowel Diseases|February 2, 2012
Pretravel preparation and travel-related morbidity in patients with inflammatory bowel diseaseDarius Soonawala, Anna M van Eggermond, Herma Fidder, et al.Inflammatory Bowel Diseases|February 2, 2012
Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseasesTrenton R Schoeb, Daniel C BullardInflammatory Bowel Diseases|January 14, 2012
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's diseaseTakahiro Inoue, Hideki Iijima, Michiko Tajiri, et al.Inflammatory Bowel Diseases|January 14, 2012
Integrated models of care in managing inflammatory bowel disease: a discussionAntonina A Mikocka-Walus, Jane M Andrews, Charles N Bernstein, et al.Inflammatory Bowel Diseases|December 1, 2011
Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel diseaseBenjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, et al.Inflammatory Bowel Diseases|November 25, 2011
Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapyYvonne Dörffel, Alexander Swidsinski, Vera Loening-Baucke, et al.Inflammatory Bowel Diseases|November 1, 2011
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus reportBrian G Feagan, Marc Lémann, Ragnar Befrits, et al.Pageof 551